1. Home
  2. BIVI vs HCTI Comparison

BIVI vs HCTI Comparison

Compare BIVI & HCTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • HCTI
  • Stock Information
  • Founded
  • BIVI 2013
  • HCTI 2020
  • Country
  • BIVI United States
  • HCTI United States
  • Employees
  • BIVI N/A
  • HCTI N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • HCTI Retail: Computer Software & Peripheral Equipment
  • Sector
  • BIVI Health Care
  • HCTI Technology
  • Exchange
  • BIVI Nasdaq
  • HCTI Nasdaq
  • Market Cap
  • BIVI 14.2M
  • HCTI 13.5M
  • IPO Year
  • BIVI N/A
  • HCTI 2021
  • Fundamental
  • Price
  • BIVI $1.50
  • HCTI $2.78
  • Analyst Decision
  • BIVI
  • HCTI
  • Analyst Count
  • BIVI 0
  • HCTI 0
  • Target Price
  • BIVI N/A
  • HCTI N/A
  • AVG Volume (30 Days)
  • BIVI 119.4K
  • HCTI 478.9K
  • Earning Date
  • BIVI 11-11-2025
  • HCTI 11-14-2025
  • Dividend Yield
  • BIVI N/A
  • HCTI N/A
  • EPS Growth
  • BIVI N/A
  • HCTI N/A
  • EPS
  • BIVI N/A
  • HCTI N/A
  • Revenue
  • BIVI N/A
  • HCTI $11,866,000.00
  • Revenue This Year
  • BIVI N/A
  • HCTI $67.59
  • Revenue Next Year
  • BIVI N/A
  • HCTI $45.16
  • P/E Ratio
  • BIVI N/A
  • HCTI N/A
  • Revenue Growth
  • BIVI N/A
  • HCTI N/A
  • 52 Week Low
  • BIVI $1.42
  • HCTI $1.37
  • 52 Week High
  • BIVI $38.50
  • HCTI $435.75
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 29.30
  • HCTI 51.30
  • Support Level
  • BIVI $1.83
  • HCTI $2.53
  • Resistance Level
  • BIVI $1.80
  • HCTI $3.14
  • Average True Range (ATR)
  • BIVI 0.10
  • HCTI 0.19
  • MACD
  • BIVI -0.03
  • HCTI -0.01
  • Stochastic Oscillator
  • BIVI 14.79
  • HCTI 41.13

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About HCTI Healthcare Triangle Inc.

Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.

Share on Social Networks: